Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

Circulating Tumor Cell

AC Camargo Cancer Centermonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Circulating Tumor Cell cohort.

Asset / SponsorPhaseRating
Piritramide
The Institute of Molecular and Translational Medicine, Czech Republic
Phase 4BB
NEPENTHE
The Institute of Molecular and Translational Medicine, Czech Republic
Phase 4BB
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Capecitabine
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
TRASTUZUMAB
AC Camargo Cancer Center
Phase 2CCC

View all 12 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:

breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →
inflammatory breast carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
HER2 positive breast carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →